Transient congenital hypothyroidism due to maternal factor

Last reviewed

🖨 Print for my doctorAdvocacy Hub →
ORPHA:238696
Who is this for?
Show terms as
1FDA treatments8Treatment centers

Where are you in your journey?

UniteRare data is sourced from FDA.gov, ClinicalTrials.gov, Orphanet, OMIM, and NORD.
Report missing data

Overview

Transient congenital hypothyroidism due to maternal factor is a temporary form of thyroid hormone deficiency present at birth that is caused by substances or conditions originating from the mother that cross the placenta and affect the newborn's thyroid function. The most common maternal factors include the transplacental passage of maternal thyrotropin receptor-blocking antibodies (TRBAb), maternal use of antithyroid medications (such as propylthiouracil or methimazole used to treat maternal Graves' disease or other hyperthyroid conditions), and excessive maternal iodine intake or deficiency. These maternal factors temporarily suppress the newborn's thyroid gland function, leading to reduced production of thyroid hormones (T3 and T4) and elevated thyroid-stimulating hormone (TSH) levels. Affected newborns may present with clinical features typical of congenital hypothyroidism, including prolonged jaundice, feeding difficulties, constipation, hypotonia (decreased muscle tone), large fontanelles, macroglossia (enlarged tongue), dry skin, hypothermia, and lethargy. If untreated, even transient hypothyroidism during the critical neonatal period can impair neurodevelopment. The condition is typically detected through newborn screening programs that measure TSH and/or T4 levels. The key distinguishing feature of this condition is its transient nature — once the maternal factor is cleared from the infant's circulation (typically within weeks to a few months), normal thyroid function is restored. Treatment involves levothyroxine (synthetic thyroid hormone) replacement therapy initiated promptly after diagnosis to ensure normal growth and neurodevelopment during the critical early postnatal period. Therapy is typically continued until the maternal factor has been cleared, after which thyroid function is reassessed. A trial off medication is usually attempted around 2–3 years of age (or earlier if the transient etiology is confirmed) to verify recovery of normal thyroid function. Maternal history, including thyroid disease status and medication use, is essential for establishing the diagnosis and distinguishing this transient form from permanent congenital hypothyroidism.

Age of Onset

Neonatal

Begins at or shortly after birth (first 4 weeks)

Orphanet ↗NORD ↗

Treatments

1 available

Clotic

clotrimazole· Laboratorios Salvat, S.A.Orphan Drug

treatment of fungal otitis externa (otomycosis) due to Aspergillus species and Candida species in patients 18 years of age and older

No actively recruiting trials found for Transient congenital hypothyroidism due to maternal factor at this time.

New trials open frequently. Follow this disease to get notified.

Search ClinicalTrials.gov ↗Join the Transient congenital hypothyroidism due to maternal factor community →

No specialists are currently listed for Transient congenital hypothyroidism due to maternal factor.

View NORD Rare Disease Centers ↗Undiagnosed Disease Network ↗

Treatment Centers

8 centers
🏥 NORD

Baylor College of Medicine Rare Disease Center

Baylor College of Medicine

📍 Houston, TX

🏥 NORD

Stanford Medicine Rare Disease Center

Stanford Medicine

📍 Stanford, CA

🔬 UDN

NIH Clinical Center Undiagnosed Diseases Program

National Institutes of Health

📍 Bethesda, MD

🔬 UDN

UCLA UDN Clinical Site

UCLA Health

📍 Los Angeles, CA

🔬 UDN

Baylor College of Medicine UDN Clinical Site

Baylor College of Medicine

📍 Houston, TX

🔬 UDN

Harvard/MGH UDN Clinical Site

Massachusetts General Hospital

📍 Boston, MA

🏥 NORD

Mayo Clinic Center for Individualized Medicine

Mayo Clinic

📍 Rochester, MN

👤 Mayo Clinic Center for Individualized Medicine

🏥 NORD

UCLA Rare Disease Day Program

UCLA Health

📍 Los Angeles, CA

Travel Grants

No travel grants are currently matched to Transient congenital hypothyroidism due to maternal factor.

Search all travel grants →NORD Financial Assistance ↗

Community

Open Transient congenital hypothyroidism due to maternal factorForum →

No community posts yet. Be the first to share your experience with Transient congenital hypothyroidism due to maternal factor.

Start the conversation →

Latest news about Transient congenital hypothyroidism due to maternal factor

No recent news articles for Transient congenital hypothyroidism due to maternal factor.

Follow this condition to be notified when news becomes available.

Caregiver Resources

NORD Caregiver Resources

Support, advocacy, and financial assistance for caregivers of rare disease patients.

Mental Health Support

Rare disease caregiving can be isolating. Connect with counseling and peer support.

Family & Caregiver Grants

Financial assistance programs specifically for caregivers of rare disease patients.

Social Security Disability

Learn how rare disease patients may qualify for SSDI/SSI benefits.

Common questions about Transient congenital hypothyroidism due to maternal factor

What is Transient congenital hypothyroidism due to maternal factor?

Transient congenital hypothyroidism due to maternal factor is a temporary form of thyroid hormone deficiency present at birth that is caused by substances or conditions originating from the mother that cross the placenta and affect the newborn's thyroid function. The most common maternal factors include the transplacental passage of maternal thyrotropin receptor-blocking antibodies (TRBAb), maternal use of antithyroid medications (such as propylthiouracil or methimazole used to treat maternal Graves' disease or other hyperthyroid conditions), and excessive maternal iodine intake or deficiency.

At what age does Transient congenital hypothyroidism due to maternal factor typically begin?

Typical onset of Transient congenital hypothyroidism due to maternal factor is neonatal. Age of onset can vary across affected individuals.

What treatment and support options exist for Transient congenital hypothyroidism due to maternal factor?

1 patient support program are currently tracked on UniteRare for Transient congenital hypothyroidism due to maternal factor. See the treatments and support programs sections for copay assistance, eligibility, and contact details.